NCT03588026Phase 3Completed

Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2020-09-03Actual

Enrollment · participants9Actual

Source updated2025-04-09Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Study details

Conditions studied

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Treatments or interventions studied

rVA576Drug

Primary outcomes · main study measures

measure: HB (Haemoglobin) stabilisation rate and the avoidance of packed red blood cells (PRBC) transfusions; description: Haemoglobin stabilisation rate defined as haemoglobin greater than the set point for each patient during the pre-study randomisation period and the avoidance of PRBC transfusions during the treatment period.; timeFrame: 9 months

History coverage

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

How to read this history